Literature DB >> 26088677

Reply to 'Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab'.

M Ho1, E C Lo1, A L Young1, D T L Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26088677      PMCID： PMC4565938          DOI： 10.1038/eye.2015.102

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab.

Authors:  C S Tan; W K Ngo; L W Lim; T H Lim
Journal:  Eye (Lond)       Date:  2015-06-19       Impact factor: 3.775

2.  Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.

Authors:  M Ho; E C F Lo; A L Young; D T L Liu
Journal:  Eye (Lond)       Date:  2014-09-26       Impact factor: 3.775

3.  A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes.

Authors:  Colin S H Tan; Wei Kiong Ngo; Louis W Lim; Tock Han Lim
Journal:  Br J Ophthalmol       Date:  2014-07-04       Impact factor: 4.638

Review 4.  Polypoidal choroidal vasculopathy.

Authors:  Antonio P Ciardella; Irene M Donsoff; Sheau J Huang; Danielle L Costa; Lawrence A Yannuzzi
Journal:  Surv Ophthalmol       Date:  2004 Jan-Feb       Impact factor: 6.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.